ReNeuron Group Plc (LON:RENE) said positive long-term data on its CTX cell therapy for stroke was presented at a US conference. Professor Keith Muir, of the Queen Elizabeth University Hospital, Glasgow, and Principal Investigator for ReNeuron’s PISCES II study, told the audience upper limb functional recovery was “durable and maintained” out to 12 months post-treatment.
Fuel cell specialist AFC Energy plc (LON:AFC) has started a search for a new chief financial officer as Richard Tuffill will be leaving at the end of March this year for personal reasons. "Richard has provided valuable support to AFC Energy since joining and has strengthened the financial, reporting and internal controls at the company with a continued strong emphasis on cash preservation and governance," the company said in a brief statement.
Amur Minerals Corp (LON:AMC) has started a new resource assessment process for the Kun Manie project, in Russia’s Far East, and it told investors to expect a substantial upgrade from last February’s mineral resource estimate. Last year’s estimate was based on deposits with a total strike length of 1.4 kilometres, whereas, following new data from the 2017 drill campaign the new assessment will estimate resources across an expanded 3.6 kilometres.
Akers Biosciences, Inc. (LONL:AKR) (NASDAQ:AKER), the developer of rapid health information technologies, has received proceeds of US$525,000 from a further exercise by warrant holders over an aggregate 2.8mln shares at an exercise price of US$0.1875 per share.